Latest filing published 16 Oct 2026 for Akari Therapeutics Plc, €43k.
This profile gathers the share dealings of Samir Rashmikant Patel in Akari Therapeutics PLC. The record holds 16 filings, for trades running from 31 May 2024 to 5 October 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 16 October 2026 with a share grant (€43k) in Akari Therapeutics PLC. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations